Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Proteomics in antitumor research (CROSBI ID 130516)

Prilog u časopisu | stručni rad

Fontana, Simona ; De Leo Giacomo ; Sedić, Mirela ; Kraljević Pavelić, Sandra ; Alessandro, Riccardo Proteomics in antitumor research // Drug discovery today. Technologies, 3 (2006), 4; 441-449

Podaci o odgovornosti

Fontana, Simona ; De Leo Giacomo ; Sedić, Mirela ; Kraljević Pavelić, Sandra ; Alessandro, Riccardo

engleski

Proteomics in antitumor research

Proteins are the molecular players of fine-tuned regulatory pathways that underlie the behavior of any cell type. Derangement of this wide protein circuitry has a profound effect on cell life and ultimately contributes to the development of diseases such as cancer. New proteomic technologies are rapidly evolving to define and characterize the nodes of this altered protein network, both inside and outside cancer cells. Hopefully, these technologies will become user-friendly laboratory tools to improve cancer management from early detection to the development of rational and patient-tailored therapeutic strategies.

proteomics; cancer; protein arrays; 2-DE; masena spektrometrija

Rad je financiran i iz sredstava s projekta Ministarstva znanosti, obrazovanja i športa "Jezgre-Test" (14M09800 ; voditelj projekta prof. dr. sci. Krešimir Pavelić)

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

3 (4)

2006.

441-449

objavljeno

1740-6749

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost